Yahoo India Web Search

Search results

    • American chemist, microbiologist, and geneticist

      • Michael Andrew Fischbach (born November 3, 1980) is an American chemist, microbiologist, and geneticist. He is an associate professor of Bioengineering and ChEM-H Faculty Fellow at Stanford University [ 1][ 2] and a Chan Zuckerberg Biohub Investigator.
      en.wikipedia.org/wiki/Michael_Fischbach
  1. People also ask

  2. Michael Fischbach is the Liu (Liao) Family Professor of Bioengineering at Stanford University, an Institute Scholar of Stanford ChEM-H, and the director of the Stanford Microbiome Therapies Initiative.

    • Sign In

      We would like to show you a description here but the site...

    • Nathan Johns

      Nathan Johns is part of Stanford Profiles, official site for...

  3. Michael Fischbach is the Liu (Liao) Family Professor of Bioengineering at Stanford University, an Institute Scholar of Stanford ChEM-H, and the director of the Stanford Microbiome Therapies Initiative.

  4. Michael Andrew Fischbach (born November 3, 1980) is an American chemist, microbiologist, and geneticist. He is an associate professor of Bioengineering and ChEM-H Faculty Fellow at Stanford University [1] [2] and a Chan Zuckerberg Biohub Investigator. [3]

  5. Michael Fischbach is the Liu (Liao) Family Professor of Bioengineering at Stanford University, an Institute Scholar of Stanford ChEM-H, and the director of the Stanford Microbiome Therapies Initiative.

  6. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. BB Williams, AH Van Benschoten, P Cimermancic, MS Donia, ... Cell host &...

  7. Michael Fischbach is the Liu (Liao) Family Professor of Bioengineering at Stanford University, an Institute Scholar of Stanford ChEM-H, and the director of the Stanford Microbiome Therapies Initiative.

  8. Michael Fischbach is the Liu (Liao) Family Professor of Bioengineering at Stanford University, an Institute Scholar of Stanford ChEM-H, and the director of the Stanford Microbiome Therapies Initiative.